Tomorrow.Bio Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Employees
  • 25

Employees

  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $5.64M

  • Investors
  • 6

Tomorrow.Bio General Information

Description

Provider of cryopreservation services intended to preserve biological processes for future medical revival. The company utilizes specialized cryoprotectant solutions and liquid nitrogen storage systems to maintain patients at sub-zero temperatures without ice crystal formation, enabling individuals to secure long-term biological preservation until medical technology can address their underlying cause of death.

Contact Information

Formerly Known As
Meisterstil UG (haftungsbeschränkt)
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Graefestraße 11
  • 10967 Berlin
  • Germany
+49 030
Primary Industry
Other Healthcare Services
Corporate Office
  • Graefestraße 11
  • 10967 Berlin
  • Germany
+49 030

Tomorrow.Bio Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Tomorrow.Bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Seed Round 22-May-2025 $5.64M Completed Generating Revenue
3. Seed Round 22-Dec-2022 Completed Generating Revenue
2. Seed Round 08-Aug-2021 Completed Generating Revenue
1. Angel (individual) Completed Startup
To view Tomorrow.Bio’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Tomorrow.Bio Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Tomorrow.Bio Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
Blast.Club Venture Capital Minority
TruVenturo Family Office Minority
Zain S Hasan Charitable Remainder Trust Venture Capital Minority
Asia Venture Group Venture Capital Minority
TEC Ventures (Germany) Venture Capital Minority
You’re viewing 5 of 6 investors. Get the full list »

Tomorrow.Bio FAQs

  • When was Tomorrow.Bio founded?

    Tomorrow.Bio was founded in 2020.

  • Where is Tomorrow.Bio headquartered?

    Tomorrow.Bio is headquartered in Berlin, Germany.

  • What is the size of Tomorrow.Bio?

    Tomorrow.Bio has 25 total employees.

  • What industry is Tomorrow.Bio in?

    Tomorrow.Bio’s primary industry is Other Healthcare Services.

  • Is Tomorrow.Bio a private or public company?

    Tomorrow.Bio is a Private company.

  • What is the current valuation of Tomorrow.Bio?

    The current valuation of Tomorrow.Bio is .

  • What is Tomorrow.Bio’s current revenue?

    The current revenue for Tomorrow.Bio is .

  • How much funding has Tomorrow.Bio raised over time?

    Tomorrow.Bio has raised $8.24M.

  • Who are Tomorrow.Bio’s investors?

    Blast.Club, TruVenturo, Zain S Hasan Charitable Remainder Trust, Asia Venture Group, and TEC Ventures (Germany) are 5 of 6 investors who have invested in Tomorrow.Bio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process